Capillary electrophoretic analyses of β-trace protein and other low molecular weight proteins in cerebrospinal fluid from patients with central nervous system diseases

Journal of Pharmaceutical and Biomedical Analysis

Volumn 15, Issue 9-10, 1997, Pages 1257-1263

  Hiraoka, Atsushi ^a   Arato, Teruyo ^b   Tominaga, Itauru ^c   Anjyo, Ayako ^d  

^a KYORIN UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

^d Bioresearch Commercial Operations   (Japan)

Author keywords

trace protein; Capillary electrophoresis; Central nervous system disease; Cerebrospinal fluid; Low molecular weight protein

Indexed keywords

ALBUMIN; ALPHA GLOBULIN; BETA GLOBULIN; GLYCOPROTEIN; IMMUNOGLOBULIN; MYELIN BASIC PROTEIN; PREALBUMIN;

CAPILLARY ZONE ELECTROPHORESIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CONFERENCE PAPER; EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION;

BETA-GLOBULINS; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, CAPILLARY; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; ISOELECTRIC FOCUSING; MENTAL DISORDERS; MOLECULAR WEIGHT; REPRODUCIBILITY OF RESULTS; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS;

EID: 0030968806     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(96)01986-3     Document Type: Conference Paper

References (16)

1. G.M. Hochwald and G.J. Thorbecke, Proc. Soc. Exp. Biol. Med., 109 (1962) 91-95.
2. J. Clausen, Proc. Soc. Exp. Biol. Med., 107 (1961) 170-172.
3. A. Hoffmann, M. Nimtz, U. Wurster and H.S. Conradt, J. Neurochem., 63 (1994) 2185-2196.
4. A. Hoffmann, H.S. Conradt, G. Gross, M. Nimtz, F. Lottspeich and U. Wurster, J. Neurochem., 61 (1993) 451-456.
5. K. Watanabe, Y. Urade, M. Maeder, C. Murphy and O. Hayaishi, Biochem. Biophys. Res. Commun., 203 (1994) 1110-1116.
6. R.A. Fishman, Cerebrospinal Fluid in Diseases of the Nervous System, pp. 186-206. W.D. Saunders Company, Philadelphia, London, Toronto (1980).
7. T.F. Chen, J.C. Strenberg and T. Sato, Rinsho Kagaku, 22 (1993) 214-219.
8. A. Hiraoka, I. Miura, M. Hattori, I. Tominaga, S. Machida, Biol. Pharm. Bull., 16 (1993) 949-952.
9. A. Hiraoka, J. Akai, I. Miura, T. Arato, M. Sato and M. Maeda, Biomed. Res. Trace Elem., 6 (1995) 29-36.
10. A.M. Parma, P.J. Marangos and F.K. Goodwin, J. Neurochem., 36 (1981) 1093-1096.
11. S.R. Cohen, R.M. Herndon and G.M. McKhan, N. Engl. G. Med., 295 (1976) 1455-1457.
12. H. Link and J.E. Olsson, Acta Neurol. Scand., 48 (1972) 57-68.
13. K. Felgenhauer, H.J. Schadlich and M. Nekic, Klin. Wochenschr., 65 (1987) 764-768.
14. C. Lumsden, in D. McAlpine, C. Lumsden and E.D. Acheson, Eds., Multiple Sclerosis, pp. 311-621. Churchill Lovingstone, London (1972).
15. Y. Sato, K. Egami, H. Natori, H. Shoji and M. Kaji, Shinkeinaika, 18 (1983) 341-345.
16. F. Wiederkehr, in Advances in A. Crambach, M.J. Dunn and B.J. Radola, Eds., Electrophoresis, pp. 241-284. VCH Publisher, Weinheim (1992).